Rb, mcl-1 and p53 expression correlate with clinical outcome in patients with liver metastases from colorectal cancer
Open Access
- 1 June 2001
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 12 (6), 779-785
- https://doi.org/10.1023/a:1011112227044
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Immunohistochemical Quantitation of Thymidylate Synthase Expression in Colorectal Cancer Metastases Predicts for Clinical Outcome to Fluorouracil-Based ChemotherapyJournal of Clinical Oncology, 1999
- Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin.Journal of Clinical Oncology, 1997
- Reappraisal of Hepatic Arterial Infusion in the Treatment of Nonresectable Liver Metastases From Colorectal CancerJNCI Journal of the National Cancer Institute, 1996
- Cellular Targets for Activation by the E2F1 Transcription Factor Include DNA Synthesis- and G1/S-Regulatory GenesMolecular and Cellular Biology, 1995
- The retinoblastoma protein and cell cycle controlCell, 1995
- P53, cell cycle control and apoptosis: Implications for cancerCancer and Metastasis Reviews, 1995
- Regulators of cell deathTrends in Genetics, 1995
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project.Journal of Clinical Oncology, 1992
- Enhancement of the antitumor effects of 5-fluorouracil by folinic acidPharmacology & Therapeutics, 1990